Sign in

CIK 0001821586

  • Large accelerated filer

MoonLake Immunotherapeutics

Sign in to watch
Ticker
MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+41 415108022
Business address
DORFSTRASSE 29, ZUG, Switzerland, 6300
Former names
Helix Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-27 Reich Kristian Chief Scientific Officer Sale 10b5-1 −1,100 $20.00 $22K 2,711,198
2026-07-22 Reich Kristian Chief Scientific Officer Sale 10b5-1 −2,448 $20.00 $49K 2,712,298
2026-07-21 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $20.02 $1.0M 2,714,746
2026-07-20 Reich Kristian Chief Scientific Officer Sale 10b5-1 −43,700 $20.09 $878K 2,764,746
2026-07-15 Reich Kristian Chief Scientific Officer Sale 10b5-1 −16,105 $20.01 $322K 2,808,446
2026-07-10 Santos da Silva Jorge Chief Executive Officer Sale 10b5-1 −68,289 $20.02 $1.4M 2,774,893
2026-07-09 Santos da Silva Jorge Chief Executive Officer Sale 10b5-1 −33,936 $20.01 $679K 2,843,182
2026-07-01 Santos da Silva Jorge Chief Executive Officer Sale 10b5-1 −47,775 $20.03 $957K 2,877,118
2026-06-22 Bodenstedt Matthias Chief Financial Officer Sale 10b5-1 −39,120 $22.04 $862K 1,115,435
2026-06-18 Bodenstedt Matthias Chief Financial Officer Sale 10b5-1 −2,794 $19.60 $55K 1,154,555
2026-06-17 BVF PARTNERS L P/IL Director Grant or award · Option to Buy +22,195 22,195
2026-06-17 Bodenstedt Matthias Chief Financial Officer Sale 10b5-1 −15,082 $19.68 $297K 1,157,349
2026-06-17 Phillips Andrew John Director Grant or award · Option to Buy +22,195 22,195
2026-06-17 Loy Spike Director Grant or award · Option to Buy +22,195 22,195
2026-06-17 Moukheibir Catherine Director Grant or award · Option to Buy +22,195 22,195
2026-06-17 Xavier Ramnik Director Grant or award · Option to Buy +22,195 22,195
2026-06-17 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $19.43 $972K 2,824,551
2026-06-16 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $18.70 $935K 2,874,551
2026-06-15 Reich Kristian Chief Scientific Officer Sale 10b5-1 −50,000 $18.89 $945K 2,924,551
2026-05-11 Bodenstedt Matthias Chief Financial Officer Sale 10b5-1 −13,653 $20.02 $273K 1,172,431

Page 1 of 10 · 184 trades